Literature DB >> 34691293

Computational analysis of cardiac structure and function in congenital heart disease: Translating discoveries to clinical strategies.

Nickolas Forsch1, Sachin Govil1, James C Perry1,2, Sanjeet Hegde2, Alistair A Young3,4, Jeffrey H Omens1,5, Andrew D McCulloch1,5.   

Abstract

Increased availability and access to medical image data has enabled more quantitative approaches to clinical diagnosis, prognosis, and treatment planning for congenital heart disease. Here we present an overview of long-term clinical management of tetralogy of Fallot (TOF) and its intersection with novel computational and data science approaches to discovering biomarkers of functional and prognostic importance. Efforts in translational medicine that seek to address the clinical challenges associated with cardiovascular diseases using personalized and precision-based approaches are then discussed. The considerations and challenges of translational cardiovascular medicine are reviewed, and examples of digital platforms with collaborative, cloud-based, and scalable design are provided.

Entities:  

Keywords:  cardiac magnetic resonance; cardiovascular medicine; congenital heart disease; statistical shape atlases; translational medicine

Year:  2020        PMID: 34691293      PMCID: PMC8528218          DOI: 10.1016/j.jocs.2020.101211

Source DB:  PubMed          Journal:  J Comput Sci


  39 in total

Review 1.  Quantification in cardiac MRI.

Authors:  R J van der Geest; J H Reiber
Journal:  J Magn Reson Imaging       Date:  1999-11       Impact factor: 4.813

Review 2.  Indications and timing of pulmonary valve replacement after tetralogy of Fallot repair.

Authors:  Tal Geva
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2006

3.  Atlas-Based Ventricular Shape Analysis for Understanding Congenital Heart Disease.

Authors:  Genevieve Farrar; Avan Suinesiaputra; Kathleen Gilbert; James C Perry; Sanjeet Hegde; Alison Marsden; Alistair A Young; Jeffrey H Omens; Andrew D McCulloch
Journal:  Prog Pediatr Cardiol       Date:  2016-08-18

4.  Evaluating re-identification risks with respect to the HIPAA privacy rule.

Authors:  Kathleen Benitez; Bradley Malin
Journal:  J Am Med Inform Assoc       Date:  2010 Mar-Apr       Impact factor: 4.497

5.  Left ventricular shape predicts different types of cardiovascular events in the general population.

Authors:  Bharath Ambale-Venkatesh; Kihei Yoneyama; Ravi K Sharma; Yoshiaki Ohyama; Colin O Wu; Gregory L Burke; Steven Shea; Antoinette S Gomes; Alistair A Young; David A Bluemke; João Ac Lima
Journal:  Heart       Date:  2016-09-30       Impact factor: 5.994

Review 6.  SimVascular: An Open Source Pipeline for Cardiovascular Simulation.

Authors:  Adam Updegrove; Nathan M Wilson; Jameson Merkow; Hongzhi Lan; Alison L Marsden; Shawn C Shadden
Journal:  Ann Biomed Eng       Date:  2016-12-08       Impact factor: 3.934

Review 7.  Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support.

Authors:  Tal Geva
Journal:  J Cardiovasc Magn Reson       Date:  2011-01-20       Impact factor: 5.364

8.  Automated cardiovascular magnetic resonance image analysis with fully convolutional networks.

Authors:  Wenjia Bai; Matthew Sinclair; Giacomo Tarroni; Ozan Oktay; Martin Rajchl; Ghislain Vaillant; Aaron M Lee; Nay Aung; Elena Lukaschuk; Mihir M Sanghvi; Filip Zemrak; Kenneth Fung; Jose Miguel Paiva; Valentina Carapella; Young Jin Kim; Hideaki Suzuki; Bernhard Kainz; Paul M Matthews; Steffen E Petersen; Stefan K Piechnik; Stefan Neubauer; Ben Glocker; Daniel Rueckert
Journal:  J Cardiovasc Magn Reson       Date:  2018-09-14       Impact factor: 5.364

9.  Physiological and phenotypic characteristics of late survivors of tetralogy of fallot repair who are free from pulmonary valve replacement.

Authors:  Alessandra Frigiola; Marina Hughes; Mark Turner; Andrew Taylor; Jan Marek; Alessandro Giardini; Tain-Yen Hsia; Kate Bull
Journal:  Circulation       Date:  2013-09-24       Impact factor: 29.690

10.  The Translational Science Benefits Model: A New Framework for Assessing the Health and Societal Benefits of Clinical and Translational Sciences.

Authors:  Douglas A Luke; Cathy C Sarli; Amy M Suiter; Bobbi J Carothers; Todd B Combs; Jae L Allen; Courtney E Beers; Bradley A Evanoff
Journal:  Clin Transl Sci       Date:  2017-09-08       Impact factor: 4.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.